Synteract Inc.

47 articles with Synteract Inc.

• 

  Syneos Health to Acquire Synteract, Expand Its Global Expertise

  10/29/2020

  Syneos Health announced on Wednesday that it has agreed to acquire Synteract, a full-service Contract Research Organization (CRO) focused on the biopharmaceutical industry.

• Synteract Augments Leadership Team for Oncology and Rare Disease Centers of Development

  9/25/2019

  Given the enhanced strategic solutions that often result from the intersecting expertise of Synteract’s centers of development, clients will derive further benefit from the therapeutic knowledge and clinical development acumen gained from these key additions.

• Synteract’s Lisa Dilworth Named To PharmaVOICE 100 — The Most Inspiring People in Life Sciences

  8/1/2019

  Synteract, an innovative CRO partnering with biotech and pharma companies to bring new medicines to market, congratulates its Vice President, Rare and Orphan Diseases, Lisa Dilworth, for being named to the 2019 PharmaVOICE 100.

• Synteract Bolsters Its Oncology, Neuro Degenerative and Rare Disease Centers of Development with Two New Executives

  4/30/2019

  Christopher Heckman to focus on Oncology Center of Development as Dr. Art Wamil joins as lead neurologist

• Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development

  11/15/2018

  KinderPharm provides advanced pharmacometric modeling and clinical trial simulation technologies coupled with juvenile formulation and toxicology services.

• Synteract’s Francoise Desir Named to the PharmaVOICE 100 — The Most Inspiring People in Life Sciences

  8/1/2018

  Respected team leader and motivator recognized for her passion and dedication in bringing clinical trials to life

• Synteract Augments Executive Team with Cheryl Murphy as Senior Vice President, Clinical Development

  7/19/2018

  Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services enabling biopharma companies to bring new medicines to market, has added Cheryl Murphy as senior vice president, Clinical Development to its executive team.

• Synteract Exhibiting and Introducing Leaders for Therapeutic Development at DIA 2018 in Boston

  6/20/2018

  ​CRO with three decades in advancing innovative therapies will highlight new focus areas at annual Drug Information Association event

• Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform

  4/19/2018

  Contract research organization, with three decades of experience in advancing innovative therapies to market, tightens its focus while increasing investment in market positioning

• Synteract Appoints Jack Shannon as New Chief Commercial Officer

  1/30/2018

  He joins Synteract from Chiltern, a Covance company, where he was vice president, Global Business Development Biopharma.

• Synteract Adds Karl Deonanan as Chief Financial Officer to Take Company Into Next Phase of Growth

  1/17/2018

  Deonanan joins Synteract from IQVIA (formerly Quintiles) where he was CFO of the organization’s Research and Development Solutions segment.

• Synteract, Inc. (San Diego) and Harrison Clinical Research GmBHh Close Deal to Form Multinational CRO

  3/4/2013

• Synteract, Inc. (San Diego) Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics

  1/30/2013

• Synteract, Inc. (San Diego) Participating in January Pharmaceutical Industry Events on the West Coast

  12/21/2012

• Gryphon-Owned Synteract, Inc. (San Diego) Agrees to Acquire Multinational CRO Harrison Clinical Research GmBH

  12/19/2012

• Synteract, Inc. (San Diego) Upgrades Safety Database Systems to Oracle Argus to Increase Efficiencies

  10/26/2012

• Synteract, Inc. (San Diego) Leadership to Provide Insights at Industry Events on Both West and East Coasts

  9/14/2012

• Synteract, Inc. (San Diego) Senior Director Olivia Montano Honored as One of the PharmaVOICE 100

  8/2/2012

• Synteract, Inc. (San Diego) to Host Joint Statistical Meeting Roundtable in San Diego

  7/24/2012

• Synteract, Inc. (San Diego) and Rempex Pharmaceuticals Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure

  5/3/2012